How to maximize clinical benefits for patients with ALK-positive non-small cell lung cancer VJOncology 3:53 8 years ago 301 Далее Скачать
Progress in the treatment of ALK-positive non-small cell lung cancer VJOncology 0:58 8 years ago 328 Далее Скачать
Maximizing the Clinical Benefit of Crizitonib in NSCLC Targeted Oncology 1:19 7 years ago 73 Далее Скачать
FDA D.I.S.C.O.: Two approvals for ALK-positive non-small cell lung cancer U.S. Food and Drug Administration 9:00 8 months ago 249 Далее Скачать
Targeted option for non-small cell lung cancer #2023 #oncology #lungcancer OncBrothers: Practice-Changing Cancer Discussions 0:50 1 year ago 412 Далее Скачать
My WHY Behind CLINICAL TRIALS For My STAGE 4 Lung Cancer! The Patient Story 0:30 6 months ago 8 466 Далее Скачать
Evolving Options in First Line Treatment of ALK Positive Non Small Cell Lung Cancer NSCLC GRACE - Global Resource for Advancing Cancer Education 3:26 7 years ago 198 Далее Скачать
ALK-positive NSCLC: the role of treatment selection and sequencing VJOncology 3:34 6 years ago 380 Далее Скачать
Ensartinib for Advanced ALK Rearranged Non-small Cell Lung Cancer UW Health 1:36 7 years ago 489 Далее Скачать
Dr. Mark Kris Discusses Crizotinib for Patients With ALK-Positive Lung Cancer OncLive 0:44 12 years ago 363 Далее Скачать
ALK+ Non-Small Cell Lung Cancer Patient Video: Anne Marie Novartis 3:20 7 years ago 5 337 Далее Скачать
Next-Generation Targeted Therapies in Non-Small Cell Lung Cancer OncLive 7:44 10 years ago 1 347 Далее Скачать